During a live event, Bruna Pellini, MD, discussed the efficacy of cemiplimab in PD-L1-high non–small cell lung cancer.

Cabometyx® is the first and only systemic therapy to be approved in the European Union for previously treated unresectable or ...

The introduction of immune checkpoint inhibitors is linked to growing disparity for those with private insurance vs those without insurance.

Scientists have uncovered a molecular "on–off" switch that helps lung adenocarcinoma—the most common form of lung cancer—grow ...

AI model calculates a protein-based stemness index to predict tumor aggressiveness and treatment resistance. Proteomic-based ...

Integrated pharmacokinetics (PK), exposure-response, safety, and efficacy data supported 6 mg/kg Q3W as the recommended Phase 2 dose (RP2D) of IBI343. This provides support for the conduct of ...

Verastem's FDA approval for KRAS-mutant LGSOC, strong pipeline, and catalysts signal growth potential. Click here to read an ...

Melanoma, the most serious skin cancer, claims thousands of lives yearly, with men dying at a higher rate due to delayed detection and treatment. Jim Crooks was shocked by his diagnosis, having no ...

Cancer can sadly affect anyone and everyone, and the signs of cancer being present in the body can vary. Recently, Redditor u ...

As cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances in diagnosis and treatment.

As cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances ...